When: Q3 earnings showing FCF stabilization AND sequential margin expansion AND management reaffirming capital return plans within 6 months

Then: Re-engage with full thesis re-evaluation

TRIM

• Revenue Q2 2026: $60.8 billion, up 28% year-over-year
• Forward P/E: 16.8x with PEG ratio of 0.83
• If quarterly capex normalizes to 2024 levels (~$37 billion annualized), normalized FCF would be ~$75 billion, implying 20x FCF multiple vs current 69x TTM FCF
• Cash position: $90 billion with quarterly operating cash flow of $32 billion
• Current ratio: 2.23 — company is not leveraged or liquidity-constrained
• Operating margins: 30%
• Entry price: $601.33; current price: $587.94 (2.3% below entry)
• 10 EMA at $589.68; stock testing this level for first time in meaningful way after 7% intraday drop on 7/30
• RSI at 46 is ambiguous (exhausted selling momentum vs. more downside); MACD at minus 8.92 with widening histogram is meaningful but not definitive
• Probability of zero Fed cuts through 2026: 89%
• Recommend trim 15-20% at market now, not waiting for 50 SMA zone — current chart structure is capping the stock
• Do NOT initiate new short exposure — shorting is speculation, not risk management
• Re-entry rule: add back only if META closes above $601.33 on volume OR tangible proof of AI ROI in advertiser CPMs at Q3 earnings
• Fortress balance sheet bounds downside — drawdowns limited by $90B cash and 2.23 current ratio in ways smaller/levered companies don't have

→ vs aggressive: Treating every bearish datapoint as definitive while dismissing forward consensus estimates (16.8x P/E, 0.83 PEG) as 'narrative capture' when they reflect analyst access to same R&D and capex data — inconsistent methodology

→ vs aggressive: The '69x TTM FCF' framing is analytically misleading at peak capex; normalized FCF at 2024 capex levels implies 20x multiple, not 69x — the aggressive analyst's 40-50% downside scenario requires multiple negative catalysts aligning in ways that ignore the $90 billion cash position and $32 billion quarterly operating cash flow

→ vs aggressive: Reading post-shock recovery (8/4 testing 10 EMA) as 'confirmed breakdown' because it fits the thesis — prior two sessions were still working off capitulation low, not establishing resistance

→ vs aggressive: The 'asymmetric downside' framing is a directional view, not risk management; aggressive analyst is asking to bet against the most sophisticated AI advertiser in the world at 16.8x forward P/E, which is not a low-risk position

→ vs aggressive: Maximum trim recommendation becomes a bet, not a hedge — if AI monetization shows up in Q3/Q4 capex commentary, this stock rips back to $600+, and maximum trim means missing the recovery with the worst timing

→ vs neutral: HOLD recommendation is too passive given the chart deterioration — the right answer is trim, not maximum, not zero

SELL (partial trim of 20-25% now, retain 50-60% core position)

• Trim 20-25% of META position at current levels (~$588) to remove immediate exposure and lock in post-capitulation bounce
• Set limit orders to trim another 10-15% on any rally into $589-$601 zone, but only if those levels are reached
• If stock breaks $539 on volume, execute additional trim at market without waiting for limit orders — conditional logic on weakness, not just strength
• Retain 50-60% of original allocation to preserve exposure to AI monetization optionality, 28% revenue growth, and Q3 catalyst
• Hard re-evaluation trigger: close above $601.33 on above-average volume invalidates bearish structure and warrants adding back to neutral weight
• Hard re-evaluation trigger: close below $539 retesting 7/30 low warrants further trimming as confirmed breakdown
• The trader's directional call (SELL, underweight) is correct but execution timing and sizing calibration are flawed
• Both aggressive and conservative analysts are partially right and partially wrong
• Mag 7 rotation is a confirmed near-term headwind; sector rotation into chips is documented
• 89% probability of zero Fed cuts means no easing tailwind in near term
• Q3 catalyst expected but not until late October creates three-month catalyst drought
• Underweight META requires clear thesis on where reallocated capital goes (semis, defensives, or cash)

→ vs aggressive: Treating a mathematically unfavorable coin-flip setup (8.2% downside vs 7.5% upside) as evidence for a 3-to-1 asymmetric short conviction

→ vs aggressive: Using 42 million shares on a gap-down as terminal proof rather than recognizing institutional players reposition constantly

→ vs aggressive: Treating 40-50% downside scenario as base case when it requires AI monetization failure, elevated capex, multiple compression, and Mag 7 rotation to occur simultaneously

→ vs aggressive: Dismissing 28% revenue growth as backward-looking when Q2 2026 was reported July 29 — only 6 days ago

→ vs aggressive: Picking worst-case FCF denominator (elevated capex) rather than normalized FCF at 2024 levels (20x multiple, not 69x)

→ vs conservative: A 15-20% trim is not a hedge if the thesis is correct — it's a 'token gesture' that won't materially reduce exposure

→ vs conservative: Re-entry rule at $601.33 is literally the trader's invalidation level, creating round-trip transaction costs with no improvement in expected outcome

→ vs conservative: Treating survival (fortress balance sheet with $90B cash) as equivalent to outperformance; in this market regime those are very different things